These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epstein-Barr virus (EBV) hypersensitivity of peripheral B lymphocytes in patients with EBV genome-positive Burkitt's lymphoma. Okano M; Mizuno F; Osato T J Infect; 1995 Jul; 31(1):15-9. PubMed ID: 8522826 [TBL] [Abstract][Full Text] [Related]
23. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002 [TBL] [Abstract][Full Text] [Related]
24. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids. Durnford JM; Scanlon PA; Glaser R J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867 [TBL] [Abstract][Full Text] [Related]
25. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH; Wills A; Reece E; Fox Z Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957 [TBL] [Abstract][Full Text] [Related]
27. Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant lymphoma. Abo W; Takada K; Kamada M; Imamura M; Motoya T; Iwanga M; Aya T; Yano S; Nakao T; Osato T Lancet; 1982 Jun; 1(8284):1272-6. PubMed ID: 6123020 [TBL] [Abstract][Full Text] [Related]
28. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment. Shapiro IM; Andersson-Anvret M; Klein G Intervirology; 1978; 10(2):94-101. PubMed ID: 209000 [TBL] [Abstract][Full Text] [Related]
29. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Clements GB; Klein G; Povey S Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210 [TBL] [Abstract][Full Text] [Related]
30. Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line. Zhang HY; Yao K; Zhu HC; Glaser R Int J Cancer; 1990 Nov; 46(5):944-9. PubMed ID: 2172173 [TBL] [Abstract][Full Text] [Related]
31. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Moar MH; Ber R; Klein G; Westman A; Eriksson I Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells. Glaser R; Nonoyama M Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214 [TBL] [Abstract][Full Text] [Related]
33. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells. Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981 [No Abstract] [Full Text] [Related]
34. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Klein G; Clements G; Zeuthen J; Westman A Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Takimoto T; Furukawa M; Hatano M; Umeda R Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641 [TBL] [Abstract][Full Text] [Related]
36. Establishment of somatic hybrid cell clones from rat embryonic fibroblast cells with Burkitt's lymphoblastoid cells using polyethylene glycol. Darai G; Doerr HW; Matz B; Flügel RM; Zentgraf H; Munk K IARC Sci Publ (1971); 1978; (24 Pt 1):571-6. PubMed ID: 221362 [No Abstract] [Full Text] [Related]
37. Epstein-Barr virus-positive Burkitt's lymphoma in a German woman during pregnancy. Bornkamm GW; Kaduk B; Kachel G; Schneider U; Fresen KO; Schwanitz G; Hermanek P Blut; 1980 Mar; 40(3):167-77. PubMed ID: 6244869 [TBL] [Abstract][Full Text] [Related]
38. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin. Shapiro IM; Luka J; Andersson-Anvret M; Klein G Intervirology; 1979; 12(1):19-25. PubMed ID: 227812 [TBL] [Abstract][Full Text] [Related]
39. Interaction between Epstein-Barr virus and type-C virus in human cells. Osato T; Yamamoto K; Matsuo T; Aya T; Mizuno F; Nonoyama M IARC Sci Publ (1971); 1978; (20):413-20. PubMed ID: 215524 [TBL] [Abstract][Full Text] [Related]
40. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding. Grogan EA; Summers WP; Dowling S; Shedd D; Gradoville L; Miller G Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7650-3. PubMed ID: 6324183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]